Tag Archives: GMO

Top 10 Warren Buffett Stocks To Buy Right Now

Warren Buffett may not have supported Donald Trump’s candidacy for president, but the 86-year-old billionaire certainly benefited from the unexpected outcome.

Stocks are up across the board since the presidential election, boosting the value of Berkshire Hathaway’s (NYSE:BRK-A) (NYSE:BRK-B) stock portfolio, but few stocks have rallied as much as Bank of America (NYSE:BAC).

The Bank of America building dominates the Dallas skyline. Image source: Getty Images.

In 2011, during the darkest days of Bank of America’s struggle to survive the fallout from the financial crisis, Buffett called the bank’s CEO Brian Moynihan with an idea. Buffett would inject $5 billion of Berkshire Hathaway’s cash into Bank of America, giving the bank a much-needed seal of approval.

But the deal had to be done on highly favorable terms to Berkshire Hathaway. Buffett demanded $5 billion worth of preferred stock yielding 6%, or $300 million a year. On top of that, the bank kicked in warrants to buy 700 million shares of Bank of America stock for $7.14 per share, exercisable at any time before the middle of 2021.

Top 10 Warren Buffett Stocks To Buy Right Now: Brown Forman Corporation(BF.B)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Brown-Forman (BF.B)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Brown-Forman (BF.B)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Garrett Baldwin]

    Now, here’s a closer look at today’s Money Morning insight, the most important market events, and stocks to watch.

    The Top Stock Market Stories for Thursday
    Investors are eyeing news that the U.S. deficit with China hit a 10-year high during December. This widening deficit occurred even in the face of U.S. President Donald Trump’s large tariffs on Chinese goods. Trump has been slapping tariffs on China to reduce this deficit. However, Americans continued to buy cheap manufactured goods while the Chinese government has scooped up cheap commodities and raw materials from other nations. Yesterday, shares of Brown-Forman Corp. (NYSE: BF.B), the manufacturer of Jack Daniel’s whiskey, fell 7% after announcing the tariffs were hurting sales. Now, new tensions in the trade deal are emerging as the Chinese tech firm Huawei has sued the U.S. government over a ban to sell its equipment to the United States.
    Before the bell, the European Central Bank planned to announce its latest decision on interest rates and other monetary policy matters. The ECB Bank Chief Mario Draghi hosted a press conference to discuss the bank’s forecast for the European economy. Many analysts project that several key markets – like Germany – have seen a cooldown in economic activity in recent months. The ECB has never raised interest rates during any part of Draghi’s eight-year term. The 2020 election is heating up around one issue – but it’s not the one that you think. In fact, Money Morning Special Situation Strategist Tim Melvin projects that President Trump will do something shocking before the election: legalize cannabis across the United States. Think that’s crazy? Well, you’d be amazed at how easy it would be. You’ll also be shocked by how much money you could make by getting out in front of this trend – check out Tim’s latest insight right here.
    Stocks to Watch Today: KR, AMZN, PEP
    Amazon.com Inc. (NASDAQ: AMZN) has learned that brick-and-mortar retail is di

  • [By Ethan Ryder]

    Brown-Forman Co. Class B (NYSE:BF.B) issued an update on its FY19 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $1.75-1.85 for the period, compared to the Thomson Reuters consensus estimate of $1.83. The company issued revenue guidance of $3.44-3.48 billion (+6-7%), compared to the consensus revenue estimate of $3.46 billion.

  • [By Money Morning Staff Reports]

    Brown Forman Corp. (NYSE: BF.B), the makers of Jack Daniels whiskey and Woodford Reserve bourbon, surged 1,830% over the last 30 years.

    Wynn Resorts Ltd. (NASDAQ: WYNN), the famous Las Vegas casino operation, popped 913% since 2002.

Top 10 Warren Buffett Stocks To Buy Right Now: Riverview Bancorp Inc(RVSB)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Fj Capital Management LLC disclosed that they own 5.6% of Riverview Bancorp Inc (NASDAQ:RVSB) in a Form 13G disclosure that was filed with the Securities and Exchange Commission (SEC) on Thursday, May 24th. The investor owns 1,273,912 shares of the stock valued at approximately $10,981,121. The reporting parties listed on the disclosure included Financial Opportunity Fund LLC, Financial Opportunity Long/Short Fund LLC, FJ Capital Management LLC and Martin S Friedman. The disclosure is available through EDGAR at this link.

  • [By Stephan Byrd]

    Charter Financial (NASDAQ: CHFN) and Riverview Bancorp (NASDAQ:RVSB) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation.

  • [By Logan Wallace]

    Riverview Bancorp (NASDAQ:RVSB) and Western New England Bancorp (NASDAQ:WNEB) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

Top 10 Warren Buffett Stocks To Buy Right Now: Lifeway Foods, Inc.(LWAY)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Lifeway Foods, Inc. (NASDAQ:LWAY) COO Edward Smolyansky sold 4,890 shares of the company’s stock in a transaction that occurred on Monday, June 11th. The shares were sold at an average price of $6.41, for a total value of $31,344.90. Following the sale, the chief operating officer now owns 993,614 shares in the company, valued at approximately $6,369,065.74. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

  • [By Logan Wallace]

    Lifeway Foods (NASDAQ:LWAY) was downgraded by equities research analysts at TheStreet from a “c-” rating to a “d” rating in a report released on Friday.

Top 10 Warren Buffett Stocks To Buy Right Now: Richmont Mines, Inc.(RIC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Riecoin (CURRENCY:RIC) traded flat against the U.S. dollar during the 1-day period ending at 23:00 PM E.T. on September 16th. Over the last week, Riecoin has traded flat against the U.S. dollar. One Riecoin coin can now be purchased for about $0.0070 or 0.00000093 BTC on major exchanges. Riecoin has a market capitalization of $308,472.00 and $0.00 worth of Riecoin was traded on exchanges in the last day.

  • [By Stephan Byrd]

    Richoux Group (LON:RIC) announced its earnings results on Tuesday. The company reported GBX (3.90) (($0.05)) earnings per share for the quarter, Bloomberg Earnings reports. Richoux Group had a negative net margin of 19.84% and a negative return on equity of 38.45%.

  • [By Stephan Byrd]

    Media headlines about Richmont Mines (NYSE:RIC) (TSE:RIC) have been trending somewhat positive this week, Accern reports. The research firm ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Richmont Mines earned a coverage optimism score of 0.03 on Accern’s scale. Accern also gave media headlines about the basic materials company an impact score of 45.3472842725256 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 10 Warren Buffett Stocks To Buy Right Now: Anavex Life Sciences Corp.(AVXL)

Advisors’ Opinion:

  • [By Shane Hupp]

    Anavex Life Sciences (NASDAQ:AVXL)’s share price shot up 4.8% during mid-day trading on Tuesday . The company traded as high as $4.35 and last traded at $3.93. 14,995 shares traded hands during mid-day trading, a decline of 98% from the average session volume of 606,708 shares. The stock had previously closed at $4.13.

  • [By Stephan Byrd]

    Schwab Charles Investment Management Inc. lifted its stake in Anavex Life Sciences Corp (NASDAQ:AVXL) by 48.8% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 76,200 shares of the biotechnology company’s stock after purchasing an additional 25,000 shares during the period. Schwab Charles Investment Management Inc.’s holdings in Anavex Life Sciences were worth $211,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    Medpace (NASDAQ: MEDP) and Anavex Life Sciences (NASDAQ:AVXL) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, valuation, risk, dividends and analyst recommendations.

  • [By Joseph Griffin]

    News coverage about Anavex Life Sciences (NASDAQ:AVXL) has been trending somewhat positive on Wednesday, according to Accern. The research firm identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Anavex Life Sciences earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned headlines about the biotechnology company an impact score of 46.5362495493017 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

  • [By Shane Hupp]

    Here are some of the media stories that may have effected Accern’s analysis:

    Get Anavex Life Sciences alerts:

    Comparing Anavex Life Sciences (AVXL) & Viralytics (VRACY) (americanbankingnews.com) Hot Move to Watch Anavex Life Sciences Corp. (AVXL) (nasdaqplace.com) Anavex Life Sciences (AVXL) and Intrexon (XON) Head to Head Review (americanbankingnews.com) -$0.10 EPS Expected for Anavex Life Sciences (AVXL) This Quarter (americanbankingnews.com)

    A number of equities analysts recently issued reports on the stock. Maxim Group reaffirmed a “buy” rating and set a $7.00 target price (up previously from $5.00) on shares of Anavex Life Sciences in a research report on Thursday, May 31st. Zacks Investment Research lowered shares of Anavex Life Sciences from a “buy” rating to a “hold” rating in a research report on Friday, March 23rd. Noble Financial set a $7.00 target price on shares of Anavex Life Sciences and gave the stock a “buy” rating in a research report on Wednesday, May 16th. HC Wainwright assumed coverage on shares of Anavex Life Sciences in a research report on Wednesday, May 30th. They set a “buy” rating and a $10.00 target price on the stock. Finally, Roth Capital initiated coverage on shares of Anavex Life Sciences in a research report on Thursday, March 8th. They set a “buy” rating and a $6.00 target price on the stock. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. Anavex Life Sciences presently has an average rating of “Buy” and an average target price of $6.55.

  • [By Joseph Griffin]

    Anavex Life Sciences (NASDAQ:AVXL) and Icon (NASDAQ:ICLR) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, institutional ownership, profitability and earnings.

Top 10 Warren Buffett Stocks To Buy Right Now: Blue Buffalo Pet Products, Inc.(BUFF)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Petmed Express and pet stock peer Central Garden & Pet Co (NASDAQ: CENT) being outstanding performers over the last year or two while pet food stocks Blue Buffalo Pet Products Inc (NASDAQ: BUFF) and Freshpet Inc (NASDAQ: FRPT) have not yet lived up to investor expectations:

  • [By Shane Hupp]

    Nestlé (OTCMKTS: NSRGY) and Blue Buffalo Pet Products (NASDAQ:BUFF) are both consumer staples companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.

  • [By ]

    Despite his deal hunger, Hayes said he is unlikely to shock investors with an outrageous purchase. In other words, nothing in the mold of cereal giant General Mills (GIS) buying natural pet food brand Blue Buffalo (BUFF) .

Top 10 Warren Buffett Stocks To Buy Right Now: General Moly, Inc(GMO)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on General Moly (GMO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Warren Buffett Stocks To Buy Right Now: Cellcom Israel Ltd.(CEL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Natural Health Trends Corp (NASDAQ: NHTC) fell 7.8 percent to $19.80 in pre-market trading after rising 1.46 percent on Friday.
    Endocyte, Inc. (NASDAQ: ECYT) shares fell 6.6 percent to $11.41 in pre-market trading after climbing 4.18 percent on Friday.
    Quorum Health Corporation (NYSE: QHC) shares fell 6.2 percent to $5.15 in pre-market trading after tumbling 11.45 percent on Friday.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) fell 6.1 percent to $7.31 in pre-market trading after declining 3.35 percent on Friday.
    Boston Scientific Corporation (NYSE: BSX) fell 5.6 percent to $28.30 in pre-market trading.
    Evofem Biosciences, Inc. (NASDAQ: EVFM) fell 5.3 percent to $6.06 in pre-market trading after gaining 2.73 percent on Friday.
    Xerox Corporation (NYSE: XRX) shares fell 5.2 percent to $28.60 in pre-market trading. Xerox terminated its transaction agreement with Fujifilm and entered into a new agreement with Carl Icahn and Darwin Deason. JP Morgan downgraded Xerox from Overweight to Neutral.
    Cellcom Israel Ltd. (NYSE: CEL) fell 5.2 percent to $7.02 in pre-market trading. Cellcom is expected to release Q1 results on May 30, 2018.
    Perrigo Company plc (NYSE: PRGO) fell 4.5 percent to $74 in pre-market trading.
    Nabriva Therapeutics plc (NASDAQ: NBRV) shares fell 4 percent to $4.66 in pre-market trading

  • [By Lisa Levin]

    Thursday afternoon, the telecommunication services shares surged 0.58 percent. Meanwhile, top gainers in the sector included Intelsat S.A. (NYSE: I), up 5 percent, and Cellcom Israel Ltd. (NYSE: CEL) up 2.5 percent.

  • [By Lisa Levin]

    Thursday afternoon, the health care shares rose 1.79 percent. Meanwhile, top gainers in the sector included Partner Communications Company Ltd. (NASDAQ: PTNR), up 8 percent, and Cellcom Israel Ltd. (NYSE: CEL) up 7 percent.

  • [By Ethan Ryder]

    Millicom (OTCMKTS: MIICF) and Cellcom Israel (NYSE:CEL) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

  • [By Ethan Ryder]

    Hellenic Telecom Organization (NYSE: CEL) and Cellcom Israel (NYSE:CEL) are both utilities companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends and analyst recommendations.

Top 10 Warren Buffett Stocks To Buy Right Now: H&R Block, Inc.(HRB)

Advisors’ Opinion:

  • [By Ethan Ryder]

    H & R Block Inc (NYSE:HRB) Director Robert A. Gerard acquired 1,000 shares of the firm’s stock in a transaction dated Friday, June 22nd. The shares were purchased at an average price of $23.18 per share, for a total transaction of $23,180.00. Following the completion of the transaction, the director now directly owns 148,579 shares in the company, valued at $3,444,061.22. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage gain ahead of the close was H&R Block, Inc. (NYSE: HRB) which traded up about 4% at $27.40. The stock’s 52-week range is $22.45 to $29.81. Volume was 4 million compared to the daily average volume of 3.3 million.

  • [By Stephan Byrd]

    H&R Block (NYSE:HRB) saw some unusual options trading on Monday. Stock traders purchased 13,239 call options on the company. This represents an increase of approximately 1,694% compared to the average daily volume of 738 call options.

  • [By Chris Lange]

    H&R Block, Inc. (NYSE: HRB) released fiscal fourth quarter financial results after markets closed Tuesday. The company reported $5.43 in earnings per share (EPS) and $2.39 billion in revenue compared with consensus estimates that called for $5.27 in EPS and $2.34 billion in revenue. The same period last year had $3.76 in EPS and $2.33 billion in revenue.

  • [By Ethan Ryder]

    ValuEngine lowered shares of H & R Block (NYSE:HRB) from a sell rating to a strong sell rating in a research note released on Wednesday.

    Several other equities research analysts have also commented on HRB. Morgan Stanley cut their price objective on H & R Block from $30.00 to $27.00 and set an equal weight rating for the company in a research note on Wednesday. They noted that the move was a valuation call. BMO Capital Markets cut their price objective on H & R Block from $29.00 to $25.00 and set a market perform rating for the company in a research note on Wednesday. BTIG Research reiterated a sell rating and set a $21.00 price objective on shares of H & R Block in a research note on Sunday, March 11th. Northcoast Research upgraded H & R Block from a neutral rating to a buy rating and cut their price objective for the stock from $25.02 to $24.69 in a research note on Monday, March 5th. Finally, Goldman Sachs Group assumed coverage on H & R Block in a research note on Tuesday, March 27th. They set a neutral rating and a $28.00 price objective for the company. Three analysts have rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating to the company. H & R Block has a consensus rating of Hold and a consensus target price of $26.21.

  • [By Logan Wallace]

    Dynamic Technology Lab Private Ltd bought a new stake in H & R Block Inc (NYSE:HRB) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 113,925 shares of the company’s stock, valued at approximately $2,595,000. H & R Block accounts for approximately 0.4% of Dynamic Technology Lab Private Ltd’s portfolio, making the stock its 24th biggest holding. Dynamic Technology Lab Private Ltd owned 0.06% of H & R Block as of its most recent filing with the Securities & Exchange Commission.

Top 10 Warren Buffett Stocks To Buy Right Now: Salesforce.com Inc(CRM)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Consumers used to have to visit a retail store to buy software. That all started to change in the early 2000s when Salesforce.com (NYSE:CRM) launched the first software-as-a-service business.

  • [By Leo Sun]

    Veeva provides cloud-based customer relationship management (CRM) services for healthcare companies. Its core products include the Veeva Vault, which tracks prescribing habits, clinical trials, and industry regulations; and the Veeva Commercial Cloud, which helps drug companies maintain customer relationships.

  • [By Trey Thoelcke]

    Salesforce.com Inc. (NYSE: CRM) EPS will show a gain of 30.7% in the next five years, if the analysts are correct, while that growth was over 24% in the past five years. The enterprise cloud computing company recently secured a deal with Apple. Salesforce shares are trading about 50% higher year to date. Watch for its report in November as well.

  • [By Stephan Byrd]

    salesforce.com (NYSE:CRM) had its price target increased by Royal Bank of Canada to $155.00 in a research report report published on Wednesday morning, The Fly reports. Royal Bank of Canada currently has an outperform rating on the CRM provider’s stock.

  • [By Shane Hupp]

    salesforce.com, inc. (NYSE:CRM) General Counsel Amy E. Weaver sold 452 shares of salesforce.com stock in a transaction dated Wednesday, May 23rd. The stock was sold at an average price of $125.95, for a total value of $56,929.40. Following the completion of the transaction, the general counsel now owns 20,718 shares of the company’s stock, valued at $2,609,432.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

  • [By Stephan Byrd]

    salesforce.com, inc. (NYSE:CRM) Chairman Marc Benioff sold 10,000 shares of the company’s stock in a transaction on Monday, February 4th. The shares were sold at an average price of $155.84, for a total value of $1,558,400.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Hot Medical Stocks To Watch For 2019

Bethesda, MD, based Investment company Absolute Investment Management Llc buys iShares Core S&P 500, iShares Core U.S. Aggregate Bond, Schwab US Aggregate Bond, United Parcel Service Inc, United States Natural Gas Fund LP, iShares Russell Mid-Cap, iShares Core S&P Mid-Cap, iShares Core S&P Small-Cap, Snap Inc, Schwab U.S. Large-Cap, sells SPDR Select Sector Fund – Health Care, ProShares Short MSCI Emerging Markets, Medical Properties Trust Inc, Vanguard FTSEEuropean, Putnam Managed Municipal Income Trust during the 3-months ended 2017-03-31, according to the most recent filings of the investment company, Absolute Investment Management Llc. As of 2017-03-31, Absolute Investment Management Llc owns 105 stocks with a total value of $14 million. These are the details of the buys and sells.

New Purchases: IVV, UNG, IJH, IWO, IWS, SCHX, SNAP, ZIXI, Added Positions: NOBL, SPY, MINT, AGG, SCHZ, UPS, IWR, IJR, GNE, AMLP, Reduced Positions: XLV, EUM, MPW, VGK, PMM, CCI, OHI, XLE, NZF, GLD, Sold Out: VNQ, KRE, AMT, DD, CUBI, KO, V, CERS, INO,

For the details of ABSOLUTE INVESTMENT MANAGEMENT LLC’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=ABSOLUTE+INVESTMENT+MANAGEMENT+LLC

Hot Medical Stocks To Watch For 2019: Occidental Petroleum Corporation(OXY)

Advisors’ Opinion:

  • [By Chris Lange]

    Occidental Petroleum Corp.’s (NYSE: OXY) short interest decreased to 8.60 million shares from the previous reading of 8.98 million. Shares recently traded at $83.69, in a 52-week range of $57.84 to $87.67.

  • [By Logan Wallace]

    Thrivent Financial for Lutherans boosted its holdings in Occidental Petroleum (NYSE:OXY) by 166.0% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 110,995 shares of the oil and gas producer’s stock after purchasing an additional 69,261 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Occidental Petroleum were worth $7,211,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Occidental Petroleum (OXY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Investors bought shares of Occidental Petroleum Co. (NYSE:OXY) on weakness during trading hours on Monday after JPMorgan Chase & Co. lowered their price target on the stock from $94.00 to $90.00. $115.60 million flowed into the stock on the tick-up and $58.20 million flowed out of the stock on the tick-down, for a money net flow of $57.40 million into the stock. Of all companies tracked, Occidental Petroleum had the 19th highest net in-flow for the day. Occidental Petroleum traded down ($0.64) for the day and closed at $78.14

Hot Medical Stocks To Watch For 2019: Artisan Partners Asset Management Inc.(APAM)

Advisors’ Opinion:

  • [By ]

    Artisan Partners Asset Management (NYSE: APAM)
    Another asset manager MLP that has piqued my interest, Artisan employs an organic, creativity-driven investment process managing money in the small-cap, mid-cap, value, and international equity spaces. All of the firm’s investment management teams are afforded autonomy in pursuit of their particular investment discipline. At the end of 2017, assets under management (AUM) stood at $115.5 billion. At around $40.70 per unit, the stock is at the upper end of its 52-week range. However, on a forward P/E basis, APAM is still attractively priced with a forward P/E of 16.6, an 11% discount to the S&P 500. It also pays a 5.9% yield.

  • [By Ethan Ryder]

    SG Americas Securities LLC acquired a new stake in shares of Artisan Partners Asset Management Inc (NYSE:APAM) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 3,026 shares of the asset manager’s stock, valued at approximately $101,000.

  • [By Logan Wallace]

    Artisan Partners Asset Management Inc (NYSE:APAM) has been assigned a consensus rating of “Hold” from the seven brokerages that are presently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a sell recommendation, two have issued a hold recommendation and two have given a buy recommendation to the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $38.00.

  • [By Ethan Ryder]

    Public Employees Retirement System of Ohio cut its holdings in Artisan Partners Asset Management Inc (NYSE:APAM) by 20.5% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 75,499 shares of the asset manager’s stock after selling 19,452 shares during the quarter. Public Employees Retirement System of Ohio owned 0.10% of Artisan Partners Asset Management worth $2,276,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    Synovus Financial Corp purchased a new stake in Artisan Partners Asset (NYSE:APAM) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 105,188 shares of the asset manager’s stock, valued at approximately $3,508,000. Synovus Financial Corp owned 0.14% of Artisan Partners Asset at the end of the most recent reporting period.

Hot Medical Stocks To Watch For 2019: Luxoft Holding, Inc.(LXFT)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Luxoft (LXFT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Luxoft (NYSE: LXFT) and Zscaler (NASDAQ:ZS) are both computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, dividends, risk and earnings.

  • [By Motley Fool Staff]

    Luxoft Holding (NYSE:LXFT) Q4 2018 Earnings Conference CallMay. 24, 2018 8:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Hot Medical Stocks To Watch For 2019: General Moly, Inc(GMO)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on General Moly (GMO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Medical Stocks To Watch For 2019: Miller Industries, Inc.(MLR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Media coverage about Miller Industries (NYSE:MLR) has been trending somewhat negative this week, Accern Sentiment reports. The research firm ranks the sentiment of news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Miller Industries earned a daily sentiment score of -0.09 on Accern’s scale. Accern also assigned news headlines about the auto parts company an impact score of 46.4626409572006 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

  • [By Ethan Ryder]

    Miller Industries (NYSE:MLR) released its quarterly earnings results on Wednesday. The auto parts company reported $0.67 earnings per share for the quarter, Bloomberg Earnings reports. Miller Industries had a net margin of 4.13% and a return on equity of 12.93%. The company had revenue of $176.89 million for the quarter.

Hot Medical Stocks To Watch For 2019: Abbott Laboratories(ABT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Dundas Partners LLP bought a new position in shares of Abbott Laboratories (NYSE:ABT) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 182,495 shares of the healthcare product maker’s stock, valued at approximately $10,435,000. Abbott Laboratories accounts for 3.2% of Dundas Partners LLP’s holdings, making the stock its 10th biggest holding.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Abbott Laboratories (ABT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Todd Campbell]

    Until competitor Abbott Labs (NYSE:ABT) won approval of its Freestyle Libre CGM last year, patients still had to use fingersticks to calibrate their CGMs. The approval of the Freestyle Libre did away with that requirement, significantly reducing patient burden and, in the process, giving Abbott Labs an edge in the CGM market.

  • [By Garrett Baldwin]

    Money Morning Technical Trading Specialist D.R. Barton, Jr., has identified a little-known way to avoid the impact of tariffs altogether – and make a killing in the process. Check out D.R.’s findings here…

    The Top Stock Market Stories for Wednesday
    Shares of Morgan Stanley (NYSE: MS) added nearly 3% in pre-market hours. The gain came after the investment reported strong earnings before the bell this morning. The company’s profitability surged 39% year over year to hit $2.44 billion. The company reported earnings per share (EPS) of $1.30 on top of $10.6 billion in revenue. Wall Street analysts expected the financial titan to report EPS of $1.08 on top of $9.96 billion in revenue. Markets will again be paying close attention to statements from Federal Reserve Bank Chair Jerome Powell. On Wednesday, Powell will wrap up his two-day testimony on Capitol Hill. As we explained yesterday, the next person who could lose his or her shirt in this trade war is you. Amazon.com Inc. (Nasdaq: AMZN) stock is sitting at an all-time high as its annual Prime Day comes to a close. Look for the firm to report some initial results from its yearly shopping holiday. Despite glitches on Monday afternoon, the firm still reported strong sales over its first 12 hours.
    Three Stocks to Watch Today: IBM, NFLX, GOOGL
    International Business Machines (NYSE: IBM) will lead a busy day of earnings reports. Wall Street will be looking for the company to report EPS of $3.03 on top of $19.66 billion in revenue. The tech giant will report earnings after the bell today. The European Commission has slapped Alphabet Inc. (Nasdaq: GOOGL) with a $5 billion antitrust fine. The EC says that it violated the law by pushing its own apps on Android phones in order to thwart its competition. The punishment comes after an investigation dating back to 2015. Shares of Netflix Inc. (Nasdaq: NFLX) have been rebounding thanks to renewed confidence from one of Wall Street’s top banks. On Tuesday, Bank

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Abbott Laboratories (ABT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Absolute Software Co. (TSE:ABT) – Research analysts at National Bank Financial issued their FY2018 EPS estimates for Absolute Software in a research note issued to investors on Monday, May 7th. National Bank Financial analyst R. Tse expects that the company will post earnings of $0.03 per share for the year.